- Active Pharmaceutical Ingredients
- Varenicline tartrate
- Aprepitant, Fosapitant Intermediates
- Fosaprepitant Dimeglumine
- Vildagliptin
- Efinaconazole
- Luliconazole Intermediate
- Gadoterate Meglumine
- Succinyl Alcohol Intermediate
- Mirabillon Intermediate
- Atazanavir Intermediate
- Intermediate
- Varenicline tartrate
- Aprepitant 287930-73-8
- Aprepitant 127852-28-2
- Aprepitant 287930-75-0
- Aprepitant 200000-59-5
- Aprepitant 155742-64-6
- Aprepitant 252742-72-6
- Fosaprepitant Dimeglumine 990-91-0
- Fosaprepitant Dimeglumine 265121-01-5
- Vildagliptin 207557-35-5
- Vildagliptin 702-82-9
- Efinaconazole 144230-50-2
- Efinaconazole 133775-25-4
- Efinaconazole 127000-90-2
- Gadoterate Meglumine
- Mirabegron
- Luliconazole 98873-55-3
- Luliconazole 126534-31-4
- Atazanavir sulfate
- Bortezomib 179324-87-9
- Bortezomib 114457-94-2
- Bortezomib 205393-22-2
- Brinzolamide
- Rivaroxaban Intermediate 446292-08-6
- Rivaroxaban Intermediate 446292-07-5
- Cinacalcet Hydrochloride 1005450-55-4
- Cinacalcet Hydrochloride 585-50-2
- Eletriptan Intermediate
- Indacaterol intermediate 312753-53-0
- Indacaterol intermediate 173140-90-4
- Sitagliptin Intermediate
- Fosanavir Calcium Intermediate
Popular information
Anti-infective medication Luliconazole 187164-19-8
【Catalog number】AP8400
【CAS #】 164650-44-6
【Molecular formula】C18H22F2N4O
【Product Brief】 Molecular formula C14H9Cl2N3S2 Molecular weight 354.28 Structural formula 威智医药 Product introduction CAS 187164-19-8 Luliconazole, the English name is Luliconazole, and the American Chemical Abstracts Registry number is cas 187164-19-8.
Luliconazole
CAS 187164-19-8
US-DMF No. 28409
Alias 4- (2,4-dichlorophenyl) -1,3-dithiopentane-2-idene-1-imidazolylacetonitrile
Catalog number AP0400
CAS # 187164-19-8
Molecular formula C14H9Cl2N3S2
Molecular weight 354.28
Structural formula
Product introduction
CAS 187164-19-8 Luliconazole, the English name is Luliconazole, and the American Chemical Abstracts Registry number is cas 187164-19-8.
Luliconazole (cas 187164-19-8) is an imidazole antifungal drug developed by Japan Pesticide Corporation. The drug was finally approved in June 2005. It has been marketed under the trade name Lulicon since July 20, 2005. The cream and lotion specifications are both 1% and are used for the following fungal infections: ringworm-athlete's foot, ringworm, Tinea cruris; Candida infection-interphalangeal erosion, abrasion; Vitiligo.
VIWIT 沪ICP备12014533号-2
